Exchange: OTC·Updated 01:33 PM EDT

MRZM Marizyme, Inc.

$0.00
$0.00
(0.00%)
Today
Mkt Cap$132.00
Vol92.00

About MRZM

Marizyme, Inc. is a medical technology company, which engages in the acquisition, development, and commercialization of therapies that minimize mortality and costs in the acute care space. It offers DuraGraft, a one-time intraoperative vascular graft treatment that improves clinical outcomes by reducing the incidence and complications of graft failure, and Krillase, a patented protease-based therapeutic. The company was founded on March 20, 2007 and is headquartered in Jupiter, FL.
50

Neutral Sentiment

How do you feel about MRZM?

Advertisement|Remove ads.